MedTrace Logo

Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes

NCT07479329 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2026-03-18

No results posted yet for this study

Summary

This multicenter observational cohort study aims to evaluate whether estimated first-trimester risk of preeclampsia (PE) is associated with subclinical atherosclerosis, cardiovascular risk profile, and cardiovascular events in women with type 1 diabetes (T1D) at least 3 years after pregnancy.

Women with T1D and at least one prior pregnancy with documented first-trimester PE screening will be classified as high or low PE risk according to validated multivariable algorithms. The presence of carotid plaques, cardiometabolic risk factors, and incident cardiovascular events will be assessed during a study visit.

Conditions

Sponsors & Collaborators

  • Hospital Universitari Mutua Terrassa

    collaborator UNKNOWN

  • Sociedad Española de Endocrinología y Nutrición

    collaborator UNKNOWN

  • Institut d'Investigacions Biomèdiques August Pi i Sunyer

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-10
Primary Completion
2028-04-30
Completion
2028-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07479329 on ClinicalTrials.gov